Search Results - "Ranck, Mark C"

RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation by Widau, Ryan C, Parekh, Akash D, Ranck, Mark C, Golden, Daniel W, Kumar, Kiran A, Sood, Ravi F, Pitroda, Sean P, Liao, Zhengkai, Huang, Xiaona, Darga, Thomas E, Xu, David, Huang, Lei, Andrade, Jorge, Roizman, Bernard, Weichselbaum, Ralph R, Khodarev, Nikolai N

“…An siRNA screen targeting 89 IFN stimulated genes in 14 different cancer cell lines pointed to the RIG-I (retinoic acid inducible gene I)–like receptor…”
Get full text

Stereotactic Body Radiation Therapy for Curative Treatment of Adrenal Metastases by Rudra, Sonali, Malik, Renuka, Ranck, Mark C., Farrey, Karl, Golden, Daniel W., Hasselle, Michael D., Weichselbaum, Ralph R., Salama, Joseph K.

“…The detection of oligometastatic adrenal metastases is increasing and there are limited data supporting the use of curative intent stereotactic body radiation…”
Get full text

Radiation Oncology Medical Student Clerkship: Implementation and Evaluation of a Bi-institutional Pilot Curriculum by Golden, Daniel W., MD, Spektor, Alexander, MD, PhD, Rudra, Sonali, MD, Ranck, Mark C., MD, Krishnan, Monica S., MD, Jimenez, Rachel B., MD, Viswanathan, Akila N., MD, MPH, Koshy, Matthew, MD, Howard, Andrew R., MD, Chmura, Steven J., MD, PhD

“…Purpose To develop and evaluate a structured didactic curriculum to complement clinical experiences during radiation oncology clerkships at 2 academic medical…”
Get full text

Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma by RANCK, Mark C, GOLDEN, Daniel W, CORBIN, Kimberly S, HASSELLE, Michael D, LIAUW, Stanley L, STADLER, Walter M, HAHN, Olwen M, WEICHSELBAUM, Ralph R, SALAMA, Joseph Kamel

“…Renal cell carcinoma (RCC) is considered radioresistant, but stereotactic radiosurgery can control intracranial metastases. Advances in radiotherapy, such as…”
Get full text

Animal models to study the mutational landscape for oral cavity and oropharyngeal cancers by Spiotto, Michael T, Pytynia, Matthew, Liu, Gene-Fu F, Ranck, Mark C, Widau, Ryan

“…Cancer is likely caused by alterations in gene structure or expression. Recently, next generation sequencing has documented mutations in 106 head and neck…”
Get full text

Racial parities in outcomes after radiotherapy for head and neck cancer by Liu, Gene‐Fu F., Ranck, Mark C., Solanki, Abhishek A., Cao, Hongyuan, Kolokythas, Antonia, Wenig, Barry L., Chen, Lucy, Ard, Stephanie, Weichselbaum, Ralph R., Halpern, Howard, Spiotto, Michael T.

“…BACKGROUND Although black patients experience worse outcomes after treatment for squamous cell carcinoma of the head and neck (HNSCC), these conclusions were…”
Get full text

Effect of postradiotherapy neck dissection on nonregional disease sites by Ranck, Mark C, Abundo, Rainier, Jefferson, Gina, Kolokythas, Antonia, Wenig, Barry L, Weichselbaum, Ralph R, Spiotto, Michael T

“…After chemoradiation for head and neck cancer, more than 90% of patients who achieve a complete clinical response on imaging have their disease regionally…”
Get more information

Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease by Corbin, Kimberly S., Ranck, Mark C., Hasselle, Michael D., Golden, Daniel W., Partouche, Julien, Wu, Tianming, Chmura, Steven J., Weichselbaum, Ralph R., Salama, Joseph K.

“…Hypofractionated image guided radiation therapy (HIGRT) is increasingly used for limited metastases. Reported studies have mostly treated small volume tumors…”
Get full text

RIG-I—like receptor LGP2 protects tumor cells from ionizing radiation by Widau, Ryan C., Parekh, Akash D., Ranck, Mark C., Golden, Daniel W., Kumar, Kiran A., Sood, Ravi F., Pitroda, Sean P., Liao, Zhengkai, Huang, Xiaona, Darga, Thomas E., Xu, David, Huang, Lei, Andrade, Jorge, Roizman, Bernard, Weichselbaum, Ralph R., Khodarev, Nikolai N.

Get full text